SLC25A22
Mitochondrial glutamate carrier 1
Also known as: EIEE3, FLJ13044, GC-1, GC1, GHC1_HUMAN, NET44
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H936
- Gene
- SLC25A22
- Ensembl
- ENSG00000177542
- Chromosome
- 11
- Canonical length
- 323 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
This gene encodes a mitochondrial glutamate carrier. Mutations in this gene are associated with early infantile epileptic encephalopathy. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
323 residues, UniProt reviewed canonical sequence.
>Q9H936|SLC25A22
1 MADKQISLPA KLINGGIAGL IGVTCVFPID LAKTRLQNQQ NGQRVYTSMS DCLIKTVRSE
61 GYFGMYRGAA VNLTLVTPEK AIKLAANDFF RHQLSKDGQK LTLLKEMLAG CGAGTCQVIV
121 TTPMEMLKIQ LQDAGRIAAQ RKILAAQGQL SAQGGAQPSV EAPAAPRPTA TQLTRDLLRS
181 RGIAGLYKGL GATLLRDVPF SVVYFPLFAN LNQLGRPASE EKSPFYVSFL AGCVAGSAAA
241 VAVNPCDVVK TRLQSLQRGV NEDTYSGILD CARKILRHEG PSAFLKGAYC RALVIAPLFG
301 IAQVVYFLGI AESLLGLLQD PQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC25A22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 120 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 120 nTPM
- cerebellum: 110 nTPM
- hippocampal formation: 95 nTPM
- pancreas: 82 nTPM
- amygdala: 81 nTPM
- basal ganglia: 55 nTPM
Single-cell type
- retinal bipolar cells: 101 nCPM
- oocytes: 51 nCPM
- cone photoreceptor cells: 37 nCPM
- pancreatic acinar cells: 28 nCPM
- brain excitatory neurons: 25 nCPM
- retinal horizontal cells: 22 nCPM
Immune cell
- memory CD8 T-cell: 3.9 nTPM
- gdT-cell: 3.7 nTPM
- non-classical monocyte: 3.5 nTPM
- intermediate monocyte: 3.3 nTPM
- eosinophil: 2.5 nTPM
- memory CD4 T-cell: 2.3 nTPM
Brain region
- hippocampal formation: 206 nTPM
- cerebral cortex: 188 nTPM
- basal ganglia: 161 nTPM
- white matter: 130 nTPM
- amygdala: 118 nTPM
- pons: 103 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC25A22.
Disease | AllUniProt
Conditions SLC25A22 is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 3 (DEE3) MIM:609304
Disease | GeneticClinVar
22 pathogenic / likely-pathogenic of 611 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Early-infantile DEE
- Early Myoclonic Encephalopathy
- Developmental and epileptic encephalopathy, 3
- SLC25A22-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aspartate transmembrane transport
- L-glutamate transmembrane transport
- malate-aspartate shuttle
- monoatomic ion transport
- regulation of insulin secretion
Molecular functions
- amino acid:proton symporter activity
- L-aspartate transmembrane transporter activity
- L-glutamate transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC25A22 as an antibody target. Whether an autoantibody or antibody against SLC25A22 could matter depends on whether native SLC25A22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC25A22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC25A22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...